REVENUE MEMORANDUM CIRCULAR NO. 47-2022 issued on April 19, 2022 publishes the letter from Food and Drug Administration OIC-Director General, Dr. Oscar G. Gutierrez, Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act), which now includes certain medicines for COVID-19 treatment.